[1] QIN W, WANG XX, DU WW, et al. Advances in the study of drug-derived, thrombocytopenia[J]. Eval Anal Drug-Use in Chin Hosp, 2017, 17 (5) :577-580. (in Chinese) 秦伟, 王晓雪, 杜雯雯, 等.药源性血小板减少症的研究进展[J].中国医院用药评价与分析, 2017, 17 (5) :577-580.
|
[2] WAN M. Clinical study on treatment of thrombocytopenia with Qihuang decoction[J]. J Hubei Univ Chin Med, 2018, 20 (4) :21-25. (in Chinese) 万敏.芪黄汤治疗血小板减少症临床研究[J].湖北中医药大学学报, 2018, 20 (4) :21-25.
|
[3] STOMAIUOLO G, AMATO A, GAETA GB. Adefovir dipivoxilassociated thrombocytopenia in a patient with chronic hepatitis B[J]. Dig Liver Dis, 2006, 38 (3) :211-212.
|
[4] SELIMOGLU MA, ERTEKIN V, KIKI I, et al. Lamivudine and thrombotic thrombocytopenic purpura:Cause or coincidence[J]. J Clin Gastroenterol, 2005, 39 (1) :82-83.
|
[5] LEBENSZTEJN DM, KACZMARSKI M. Lamivudine-associated thrombocytopenia[J]. Am J Gastroenterol, 2002, 97 (10) :2687-2688.
|
[6] GEORGE JN, ASTER RH. Drug-induced thrombocytopenia:Pathogen-esis, evaluation, and management[J]. Hematology Am Soc Hematol Educ Program, 2009, 2009:153-158.
|
[7] KIM JT, JEONG HW, CHOI KH, et al. Delayed hypersensitivity reaction resulting in maculopapular-type eruption due to entecavir in the treatment of chronic hepatitis B[J]. World J Gastroenterol, 2014, 20 (42) :15931-15936.
|